Measurement of exhaled alveolar nitrogen oxide in patients with lung cancer: a friend from the past still precious today
Nitric oxide (NO) is a marker of airway inflammation and indirectly a general indicator of inflammation and oxidative stress. NO is a contributing factor in lung cancer at an early stage and also after chemotherapy treatment of lung cancer. We studied whether exhaled NO levels were altered by three...
Main Authors: | Kallianos, Anastasios, Tsimpoukis, Sotirios, Zarogoulidis, Paul, Darwiche, Kaid, Charpidou, Andriani, Tsioulis, Ilias, Trakada, Georgia, Porpodis, Konstantinos, Spyratos, Dionysios, Panoutsopoulos, Athanasios, Veletza, Lemonia, Kostopoulos, Konstantinos, Kostopoulos, Charalampos, Karapantzos, Ilias, Tsakiridis, Kosmas, Hohenforst-Schmidt, Wolfgang, Zarogoulidis, Konstantinos, Rapti, Aggeliki, Syrigos, Konstantinos |
---|---|
Format: | Online |
Language: | English |
Published: |
Dove Medical Press
2013
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3686538/ |
Similar Items
-
Clinical differences between H3N2 and H1N1 influenza 2012 and lower respiratory tract infection found using a statistical classification approach
by: Petridis, Dimitris, et al.
Published: (2014) -
Immunomodifiers in combination with conventional chemotherapy in small cell lung cancer: a Phase II, randomized study
by: Zarogoulidis, Konstantinos, et al.
Published: (2013) -
Reduction of exercise capacity in sarcoidosis in relation to disease severity
by: Kallianos, Anastasios, et al.
Published: (2015) -
Docetaxel-carboplatin in combination with erlotinib and/or bevacizumab in patients with non-small cell lung cancer
by: Boutsikou, Eftimia, et al.
Published: (2013) -
Learning from the Cardiologists and Developing Eluting Stents Targeting the Mtor Pathway for Pulmonary Application; A Future Concept for Tracheal Stenosis
by: Zarogoulidis, Paul, et al.
Published: (2013)